Drugs / FOL-005
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT02793557 | Jan 2016 → Mar 2017 | alopecia, hypertrichosis | Follicum AB | Completed | No outcome recorded |
| Phase 22 trials | ||||||
| Phase 2 | NCT04774874 | Jun 2020 → Jan 2021 | androgenetic alopecia | Follicum AB | Completed | No outcome recorded |
| Phase 2 | NCT03467412 | Feb → Aug 2018 | androgenetic alopecia | Follicum AB | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FOL-005 | “FOL-005 topical formulation (at 0.1%, 0.5% and 1.5% strength)” NCT04774874 ↗ |
| Route | Topical | “Topical administration on the scalp once daily for 16 weeks” NCT04774874 ↗ |